ClinicalTrials.gov
public full text
Public Domain
Identifying Subgroups With High Cardiovascular Risk in Breast Cancer Survivors
The purpose of this study is to evaluate the prevalence of (sub)clinical cardiovascular disease, cardiovascular risk factors and metabolic abnormalities among long-term breast cancer survivors treated with or without anthracyclines in order to identify patients at increased risk of developing cardiovascular disease.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Prospective Observational Study in Patients With Metastatic Breast Cancer Treated With Anthracyclines#887411
- ML Score Prediction of Cardiotoxicity in Cancer Patients Receiving Anthracycline Chemotherapy or HER2-Targeted Therapies#1007335
- Data for: "Assessing the association between endocrine therapy use in female breast cancer survivors and subsequent risk of cardiovascular disease"#206157
- Cardiorespiratory fitness, polygenic risk, and breast cancer in postmenopausal women: a prospective cohort study#18873
- Pre-frailty and frailty as independent predictors of mortality in U.S. breast cancer survivors: Evidence from the national health interview survey, 1997 to 2018: Frailty and all-cause mortality.#670998
Record · ID 1008009
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive